Literature DB >> 8530097

Mouse hepatitis virus-3 induced prothrombinase (Fgl2) maps to proximal chromosome 5.

S T Qureshi1, S Clermont, J Leibowitz, L S Fung, G Levy, D Malo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530097     DOI: 10.1006/geno.1995.1256

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


× No keyword cloud information.
  5 in total

1.  Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase.

Authors:  J W Ding; Q Ning; M F Liu; A Lai; J Leibowitz; K M Peltekian; E H Cole; L S Fung; C Holloway; P A Marsden; H Yeger; M J Phillips; G A Levy
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

2.  Loss of resistance to murine hepatitis virus strain 3 infection after treatment with corticosteroids is associated with induction of macrophage procoagulant activity.

Authors:  R J Fingerote; M Abecassis; M J Phillips; Y S Rao; E H Cole; J Leibowitz; G A Levy
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

3.  The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis.

Authors:  Philip A Marsden; Qin Ning; Laisum S Fung; Xioping Luo; Yue Chen; Michael Mendicino; Anand Ghanekar; Jeremy A Scott; Teresa Miller; Camie W Y Chan; Mathew W C Chan; Wei He; Reginald M Gorczynski; David R Grant; David A Clark; M James Phillips; Gary A Levy
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

4.  The nucleocapsid protein of SARS-CoV induces transcription of hfgl2 prothrombinase gene dependent on C/EBP alpha.

Authors:  Meifang Han; Weiming Yan; Yuancheng Huang; Huaning Yao; Zhanhui Wang; Dong Xi; Weina Li; Yaoyong Zhou; Jinlin Hou; Xiaoping Luo; Qin Ning
Journal:  J Biochem       Date:  2008-04-04       Impact factor: 3.387

Review 5.  Human genetic basis of fulminant viral hepatitis.

Authors:  Emmanuelle Jouanguy
Journal:  Hum Genet       Date:  2020-04-13       Impact factor: 4.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.